Clinical trials
Terminated Phase 3 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 1 |
| Bradmer Pharmaceuticals Inc. | 1 |
| DelMar Pharmaceuticals, Inc. | 1 |
| Diffusion Pharmaceuticals Inc | 1 |
| Institut Claudius Regaud | 1 |
| Isarna Therapeutics GmbH | 1 |
| University of South Florida | 1 |
| Wake Forest University Health Sciences | 1 |
| michal roll | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 9 |
| Astrocytoma | 3 |
| Brain Neoplasms | 3 |
| Glioma | 3 |
| Neoplasms | 3 |
| Oligodendroglioma | 2 |
| Body Weight Changes | 1 |
| Bone Neoplasms | 1 |
| Cachexia | 1 |
| Central Nervous System Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.